Researcher Spotlight: Caitlin Gribbin, MD NEW YORK-PRESBYTERIAN/WEILL CORNELL The Kellie and Jeff Fellinge Scholar The follicular lymphoma (FL) tumor microenvironment is made up of a wide variety of non-lymphoma cells that contribute to the growth and progression of tumor cells.…
Researcher Spotlight: Danielle Wallace, MD UNIVERSITY OF ROCHESTER Mindy Camp Fedida Memorial Scholar Older patients with diffuse large B-cell lymphoma (DLBCL) are often treated with lower doses of chemotherapy, which may contribute to an incomplete cure of the disease. Residual…
Researcher Spotlight: Lauren Shea, MD UNIVERSITY OF ALABAMA Better therapies are needed for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), and Dr. Shea’s research aims to identify a novel, improved treatment approach in this setting. The EZH1/2 inhibitor…
Researcher Spotlight: Christina Poh, MD UNIVERSITY OF WASHINGTON/FRED HUTCHINSON CANCER CENTER Stephanie A. Gregory, MD Distinguished Scholar Survival outcomes with peripheral T-cell lymphoma (PTCL) are poor, with many patients relapsing after their first line of treatment and only about 1…
Researcher Spotlight: Mwanasha Merrill, MD DANA-FARBER CANCER INSTITUTE Diagnosis of lymphoma is currently based on the use of biopsies and imaging scans to detect cancer cells and tumors. Challenges exist with the use of these techniques, though – biopsies can…
Researcher Spotlight: Jordan Goldstein, MD STANFORD UNIVERSITY Errol M. Cook Memorial Scholar Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma, with many patients experiencing relapse after first-line therapy. Many patients now receive treatment with a chimeric…
Researcher Spotlight: Adam DuVall, MD UNIVERSITY OF CHICAGO Chike Springer Foundation Scholar Adolescents and young adults with cancers such as lymphoma have unique emotional and psychosocial needs as a result of their disease and treatment. While survival outcomes rates are…
Researcher Spotlight: Moah Soan, DVM, PhD ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Jaime Peykoff Follicular Lymphoma Fellow Breakthrough therapies such as chimeric antigen receptor (CAR) T-cell therapies and bispecific antibodies have transformed the care of patients with follicular lymphoma…
Researcher Spotlight: Vignesh Shanmugam, MD BRIGHAM AND WOMEN’S HOSPITAL, INC. Tom Condon Family Fellow In many types of lymphoma, such as follicular lymphoma (FL), tumor cells are embedded in a rich microenvironment of non-malignant cells with which they regularly interact.…
Researcher Spotlight: Michael Schneider, MD, PhD THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA Treatment of lymphoma has been revolutionized by the development of chimeric antigen receptor (CAR) T-cell therapies, which elicit robust responses in many patients. However, a large number…